 | ||
Optaflu is a cell culture derived influenza vaccine manufactured by Novartis.
History
On April 27, 2007 Novartis received a positive opinion supporting European Union approval of Optaflu. It is the first influenza vaccine made in a mammalian cell line, rather than chicken eggs. The vaccine will be manufactured in Holly Springs, North Carolina. The United States government is providing $500 million in construction costs and guaranteed vaccine purchases.
References
Optaflu Wikipedia(Text) CC BY-SA